Article thumbnail

Requirement of Interaction between Mast Cells and Skin Dendritic Cells to Establish Contact Hypersensitivity

By Atsushi Otsuka, Masato Kubo, Tetsuya Honda, Gyohei Egawa, Saeko Nakajima, Hideaki Tanizaki, Bongju Kim, Satoshi Matsuoka, Takeshi Watanabe, Susumu Nakae, Yoshiki Miyachi and Kenji Kabashima


The role of mast cells (MCs) in contact hypersensitivity (CHS) remains controversial. This is due in part to the use of the MC-deficient Kit W/Wv mouse model, since Kit W/Wv mice congenitally lack other types of cells as a result of a point mutation in c-kit. A recent study indicated that the intronic enhancer (IE) for Il4 gene transcription is essential for MCs but not in other cell types. The aim of this study is to re-evaluate the roles of MCs in CHS using mice in which MCs can be conditionally and specifically depleted. Transgenic Mas-TRECK mice in which MCs are depleted conditionally were newly generated using cell-type specific gene regulation by IE. Using this mouse, CHS and FITC-induced cutaneous DC migration were analyzed. Chemotaxis assay and cytoplasmic Ca2+ imaging were performed by co-culture of bone marrow-derived MCs (BMMCs) and bone marrow-derived dendritic cells (BMDCs). In Mas-TRECK mice, CHS was attenuated when MCs were depleted during the sensitization phase. In addition, both maturation and migration of skin DCs were abrogated by MC depletion. Consistently, BMMCs enhanced maturation and chemotaxis of BMDC in ICAM-1 and TNF-α dependent manners Furthermore, stimulated BMDCs increased intracellular Ca2+ of MC upon direct interaction and up-regulated membrane-bound TNF-α on BMMCs. These results suggest that MCs enhance DC functions by interacting with DCs in the skin to establish the sensitization phase of CHS

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1997). A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.
  2. (1988). A novel form of TNF/ cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF.
  3. (2010). Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice.
  4. (1997). Activated skin mast cells are involved in murine hair follicle regression (catagen).
  5. (2006). Ca2+ influx through CRAC channels activates cytosolic phospholipase A2, leukotriene C4 secretion, and expression of c-fos through ERK-dependent and -independent pathways in mast cells.
  6. (2010). Compensatory role of Langerhans cells and langerin-positive dermal dendritic cells in the sensitization phase of murine contact hypersensitivity.
  7. (2009). Cultured human melanocytes express functional toll-like receptors 2-4, 7 and 9.
  8. (1997). Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue.
  9. (1994). Fibronectin receptor integrins are involved in mast cell activation.
  10. (2007). Identification of a novel population of Langerin+ dendritic cells.
  11. (2004). IgE-mediated mast cell activation induces Langerhans cell migration in vivo.
  12. (2006). IgEactivated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells.
  13. (2004). Immune sensitization in the skin is enhanced by antigen-independent effects of IgE.
  14. (2008). Immunomodulatory mast cells: negative, as well as positive, regulators of immunity.
  15. (1998). Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity.
  16. (2011). In Vivo Imaging of T-Cell Motility in the Elicitation Phase of Contact Hypersensitivity Using Two-Photon Microscopy.
  17. (1998). Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation.
  18. (2010). Langerhans cells and more: langerinexpressing dendritic cell subsets in the skin.
  19. (1996). Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.
  20. (2010). Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice.
  21. (2006). Mast cellassociated TNF promotes dendritic cell migration.
  22. (2003). Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1.
  23. (2010). Prostaglandin I2-IP signaling promotes Th1 differentiation in a mouse model of contact hypersensitivity.
  24. (2004). Prostanoids in the cutaneous immune response.
  25. (2007). Regulation of the Il4 gene is independently controlled by proximal and distal 39 enhancers in mast cells and basophils.
  26. (2010). Rho-mDia1 pathway is required for adhesion, migration, and T-cell stimulation in dendritic cells.
  27. (2011). Skin as a Peripheral Lymphoid Organ: Revisiting the Concept of Skin-Associated Lymphoid Tissues.
  28. (1994). Synthesis of interleukin-1 alpha and beta by normal human melanocytes.
  29. (1997). T-cell subsetspecific expression of the IL-4 gene is regulated by a silencer element and STAT6.
  30. (2003). The DP receptor, allergic inflammation and asthma.
  31. (1984). Unequivocal delayed hypersensitivity in mast celldeficient and beige mice.